Last week, the U.S. Food and Drug Administration approved the drug semaglutide, commonly known as Wegovy or Ozempic, to be used to reduce the risk of cardiovascular death, heart attack and stroke in adults with heart disease and obesity. Eric…
Tag: Heart Disease
8 Key Facts About Statins and Cholesterol
Statins can help lower cholesterol and reduce the risk of heart attacks, stroke and other heart and vascular problems. But they aren’t right for all patients, and they can rarely cause side effects. Cardiologist Melissa Tracy answers patients’ most frequently asked questions about statins.
Women’s Hearts Differ From Men’s
Heart disease is the No. 1 cause of death in the U.S. for both men and women, but from pregnancy risks to how their arteries function women face different challenges in the prevention, diagnosis and treatment of cardiovascular conditions.
Cleveland Clinic Among First Hospitals to Perform New Tissue-Sparing Ablation Procedure
Cleveland Clinic Among First Hospitals to Perform New Tissue-Sparing Ablation Procedure
Healthcare leaders plea to reinstate the Canadian hypertension control program to prevent death and disability
A passionate plea for the re-establishment of Canada’s health coalition focused on hypertension prevention and control appears as an editorial in the Canadian Journal of Cardiology, published by Elsevier.
Intravascular Imaging Significantly Improves Survival, Safety, and Outcomes in Cardiovascular Stenting Procedures Over Conventional Angiography
Results from this large-scale synthesis of all prior clinical trials could increase usage of several types of high-resolution imaging for guiding interventional coronary procedures
Could Ultra-processed Foods Be the New ‘Silent’ Killer?
Hundreds of novel ingredients never encountered by human physiology are now found in nearly 60 percent of the average adult’s diet and nearly 70 percent of children’s diets in the U.S. An emerging health hazard is the unprecedented consumption of these ultra-processed foods in the standard American diet. This may be the new “silent” killer, as was unrecognized high blood pressure in previous decades.
MSU researchers create more realistic synthetic human mini hearts, gain worldwide recognition
Thanks to advancements in the development of patented synthetic human-like hearts first created at Michigan State, researchers can study human heart development and congenital heart disease on highly accurate models. This is facilitating the development of new therapies and pharmaceutical drugs to treat a variety of heart-related diseases just in time for the observance of American Heart Month in February.
Cleveland Clinic-Led Study Discovers Link between High Levels of Niacin – a Common B Vitamin – and Heart Disease
Cleveland Clinic researchers have identified a new pathway that contributes to cardiovascular disease associated with high levels of niacin, a common B vitamin previously recommended to lower cholesterol.
Clues to cancer drug’s deadly side effects could make it safer
For some leukemia patients, their only treatment option carries a risk of heart failure
Should heart patients consider taking weight loss medications?
Over the last year, prescriptions for medications that can accelerate weight loss in people with diabetes, or without it, have skyrocketed. But how can these weight loss medications affect the heart? A preventive cardiologist shares how this shifting landscape might affect cardiovascular care and how he advises his patients.
Almost 50% of Patients Under 60 Years Choose TAVR Over Surgical Aortic Valve Replacement with Worse Outcomes
In a study presented at The Society of Thoracic Surgeons’ 2024 Annual Meeting in San Antonio, Texas, researchers examined outcomes for patients undergoing SAVR and those undergoing TAVR from 2013 to 2021 in the state of California.
Mount Sinai Renames Top-Ranked Heart Hospital to Honor Valentin Fuster, MD, PhD, and His Legacy of Excellence
“Mount Sinai Fuster Heart Hospital” furthers vision of world-leading cardiac care and research that prevents heart disease worldwide
BGSU research examines connection between loneliness and predictors of increased risk of heart disease
Research will focus on understanding what it takes for lonely individuals to build social connections and how those interactions affect the sympathetic nervous system
High Pregnancy Weight Gain Tied to Higher Risk of Later Death
Findings from 50 years of data highlighted the health risks when more weight is gained in pregnancy than recommended, especially when it comes to heart disease- and diabetes-related mortality
Walgreens and the Cardiovascular Research Foundation Unite to Improve Recognition and Diagnosis of Valvular Heart Disease for Older Americans
Walgreens and the Cardiovascular Research Foundation (CRF) today announced a collaboration to drive forward the PREVUE-VALVE study, a groundbreaking population-based clinical trial that aims to quantify the prevalence of valvular heart disease (VHD) among older Americans and pave the way for the development of new therapies and tools for VHD detection and diagnosis.
After 50 years of pioneering research in rural Louisiana, study pivots from heart to brain
A study spent 50 years tracking the health of a rural Louisiana town’s children into adulthood and found that heart disease starts in childhood. Now the study hopes decades of heart research can unlock the origins of dementia.
UCLA-led team finds a stem-cell derived mechanism that could lead to regenerative therapies for heart damage
A UCLA-led team has identified an essential internal control mechanism that can promote the maturation of human stem cell-derived heart muscle cells, possibly leading to new therapies for heart disease and cardiac damage.
CRF Announces the 2023 Pulse-Setter Award Winners
The Cardiovascular Research Foundation (CRF) is proud to announce the winners of the 2023 Pulse-Setter Awards. The awardees will be honored at The Annual Pulse of the City Gala, CRF’s signature fundraising event, on December 8, 2023, at The Plaza in New York City. The Pulse-Setter Awards shine a spotlight on extraordinary individuals and initiatives whose dedication to innovation is driving positive change in medicine and health care.
Maternal obesity predicts heart disease risk better than pregnancy complications
Pregnancy complications such as preeclampsia and gestational diabetes have recently been associated with a higher risk of developing heart disease later in life. But a new Northwestern Medicine study has found obesity before or during pregnancy is the actual root cause of future cardiovascular disease.
Heart disease risk, prevention and management redefined
Health experts are redefining cardiovascular disease (CVD) risk, prevention and management, according to a new American Heart Association presidential advisory published today in the Association’s flagship journal Circulation.
Baylor Scott & White Presents Research At The Heart Failure Society of America Annual Scientific Meeting 2023
The Heart Failure Society of America (HFSA) is a multidisciplinary organization working to improve and expand heart failure care through collaboration, education, research, innovation and advocacy. Its annual scientific meeting held Oct. 6-9, in Cleveland offers the best heart failure…
Mount Sinai Announces Partnership With the Chiba Institute of Technology in Japan Focusing on Artificial Intelligence to Transform Cardiovascular Research
Agreement aims to help make clinical trials more efficient and lead to faster advances in patient care
Largest-Ever Genetic Study of Suicide Finds New Risk Factors
The reasons why people attempt suicide are complex and include external triggers like trauma and stress, as well as inherited genetic factors. A new study has identified 12 DNA variants, or variations in the human genetic code, that are associated with risk of attempting suicide.
Preschoolers From Low-Income Families May Have Worse Health and Benefit Less From Health Promotion Interventions Than Children With Higher Socioeconomic Status
Mount Sinai study focused on Harlem preschools emphasizes the need for specialized health promotion programs in classrooms starting at an early age
Mount Sinai Researchers Develop Novel, Automated Measure of Sleep Studies to Determine Severity of Obstructive Sleep Apnea
New method can predict risks of cardiovascular disease, mortality in sleep apnea patients
New Study Confirms HeartFlow FFRCT Leads to Improved Patient Outcomes
A diagnostic test, first offered in the United States at University Hospitals Harrington Heart & Vascular Institute, has now shown through a clinical study to significantly decrease cardiovascular mortality, reduce additional non-invasive heart testing, and increase cath lab efficiency.
Virtual drug quiets noise in heart tissue images
Researchers at Washington University in St. Louis have developed a new computational approach to removing movement in images of expanding and contracting heart cells and tissues. By computationally removing movement, the algorithm mimics a drug’s action in stopping the heart, without compromising cellular structure or tissue contractility.
CRF Announces TCT 2023 Late-Breaking Clinical Trials
The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 late-breaking clinical trials. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine.
MEDIA ADVISORY: Cedars-Sinai Experts Available to Discuss Safety, Benefits of Using Medications to Lose Weight
The science is unclear on exactly why an increasingly popular new class of federally approved diabetes and obesity medications work, but they do know that they are effective at helping people lose weight.
The Medical Minute: Pediatric congenital heart disease patients need help transitioning to adulthood
Parents can be so protective of a child with congenital heart disease they often forget what comes next. When should they start learning to take care of their own condition? Two Penn State Health experts share their views.
The Medical Minute: Understanding hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy can cause sudden death at any age – but particularly in young people. A Penn State Health heart surgeon discusses prevention.
Excess Testosterone Can Lead to Increased Cardiovascular Risks in People with Polycystic Ovary Syndrome
Article title: Testosterone-associated blood pressure dysregulation in women with androgen excess polycystic ovary syndrome Authors: Tori Stone, Licy L. Yanes Cardozo, Toni N. Oluwatade, Cheryl A. Leone, Melanie Burgos, Faith Okifo, Lubna Pal, Jane F. Reckelhoff, Nina. S. Stachenfeld From…
Researchers Use Raman Microspectroscopy to Learn about Cardiomyopathy Mechanisms
Article title: Exploring the relationship between epigenetic DNA methylation and cardiac fibrosis through Raman microspectroscopy Authors: Lucas Becker, Ivonne A. Montes-Mojarro, Shannon Lee Layland, Ali Nsair, Falko Fend, Julia Marzi, Katja Schenke-Layland From the authors: “In this study, we used…
These Foods Can Help You Live Longer and Protect the Planet
Eating more planet-friendly foods could help you live a longer, healthier life, according to new research.
Alcohol Use, Even at Low Levels, Increases Risk of Developing Disease
Even low levels of alcohol use can increase the likelihood of developing diseases like cancer and heart disease. A systematic review of studies of the relationship between alcohol use and risk of disease published in Alcohol: Clinical and Experimental Research found that disease risk increases as alcohol use increases and high levels of alcohol use have clear detrimental health effects. While lower-level alcohol use can be protective against certain diseases, it can have significant adverse health effects for many other diseases. The authors urge greater awareness that any level of alcohol use can increase a person’s risk of developing serious, even fatal, diseases.
Researchers uncover how a genetic mutation can cause individuals with normal cholesterol levels to develop coronary artery disease at a young age
A novel molecular pathway to explain how a mutation in the gene ACTA2 can cause individuals in their 30s – with normal cholesterol levels and no other risk factors — to develop coronary artery disease has been identified, according to researchers with UTHealth Houston.
Martin/Hopkins Method to Calculate LDL Or ‘Bad’ Cholesterol Outperforms Other Equations, Study Shows
In a new large, comprehensive analysis that looked at data from more than 5 million patients, the Martin/Hopkins method developed by Johns Hopkins researchers to calculate low-density lipoprotein (LDL) cholesterol — so-called bad cholesterol — produces higher accuracy rates than the nearly two dozen other available equations.
9 Warning Signs of a Heart Attack from Your Body a Month Before
The No. 1 cause of death in both men and women is heart disease. Heart attacks do not always happen like they do in the movies. Heart attacks can happen suddenly or silently, but warning signs may occur for many…
Climbing to New Heights After Robotic Coronary Artery Bypass Graft
The summit is a good place to be. Staying active on the hiking trails around the southern highlands of Australia, where he retired earlier this year after a career in film marketing, Jon Anderson is feeling there’s little he can’t conquer.
TCT 2023 Program Guide Now Available
The Cardiovascular Research Foundation (CRF) has announced the TCT 2023 Program Guide is now available. TCT is the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. TCT 2023 will take place October 23-26 in San Francisco, California, at the Moscone Center and will celebrate 35 years of leading the field.
Revolutionizing Cardiology: AI-Based Technology Offers Accurate Analysis of Cardiac Disease
New research shows AI-based automated quantitative coronary angiography (AI-QCA) holds promise for accurate analysis of heart disease
TVT 2023 Late-Breaking Science Announced
The Cardiovascular Research Foundation (CRF) announced that TVT: The Structural Heart Summit will feature 15 Late-Breaking Clinical Science studies. An annual meeting featuring cutting-edge research and techniques for structural heart interventions, TVT will take place June 7-10, 2023, at the Phoenix Convention Center – West in Phoenix, Arizona.
Air pollution exposure associated with increased risk of irregular heartbeat: Large study
Does air pollution affect your heart? Acute exposure to air pollution was found to be associated with an increased risk of arrythmia — irregular heartbeat — in a large study of 322 Chinese cities published in CMAJ
Talking therapies could reduce future risk of cardiovascular disease
Using talking therapies to effectively treat depression in adults over the age of 45 may be linked with reduced rates of future cardiovascular disease, finds a new analysis of health data led by UCL researchers.
Breaking Research That Could Improve Cardiac Care for Children Published in AACC’s The Journal of Applied Laboratory Medicine
A first-of-its-kind study has established pediatric reference intervals for two common tests for cardiovascular disease. Published in AACC’s The Journal of Applied Laboratory Medicine, these findings are crucial to advancing diagnosis and treatment of heart conditions in children.
Researchers Explore Sex Differences in Cardiovascular and Congenital Heart Diseases in People with Down Syndrome
Article title: Sex differences in cardiovascular disease and dysregulation in Down syndrome Authors: Melissa L. Bates, Anastasiia Vasileva, Laura D.M. Flores, Yana Pryakhina, Michelle Buckman, Michael H. Tomasson, Lara R. DeRuisseau From the authors: “Based on the results of our…
TCT 2023 Career Achievement Award to be Presented to Stuart J. Pocock, PhD
The TCT 2023 Career Achievement Award will be presented to Stuart J. Pocock, PhD, during Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT will take place October 23-26, 2023, in San Francisco at the Moscone Center. The award is given each year to an outstanding individual who has made significant contributions to the field of interventional cardiology and transformed patient care through their career endeavors, research pursuits, and mentorship.
A Registered Dietitian’s Reaction to the New FDA Proposed Rule on Salt
According to the American Heart Association, roughly 90% of Americans are overdoing it on salt, consuming over twice the daily recommended amount. The U.S. Food and Drug Administration (FDA) announced recently it was proposing a rule to allow the use of salt…
Genetic tests unexpectedly find genes linked to heart disease — now what?
As health care professionals, researchers and consumers increasingly use genetic testing, they are uncovering incidental genetic abnormalities, or variants, that are associated with cardiovascular diseases.